US5741908A
(en)
|
1996-06-21 |
1998-04-21 |
Minnesota Mining And Manufacturing Company |
Process for reparing imidazoquinolinamines
|
UA67760C2
(uk)
|
1997-12-11 |
2004-07-15 |
Міннесота Майнінг Енд Мануфакчурінг Компані |
Імідазонафтиридин та тетрагідроімідазонафтиридин, фармацевтична композиція, спосіб індукування біосинтезу цитокінів та спосіб лікування вірусної інфекції, проміжні сполуки
|
US6518280B2
(en)
|
1998-12-11 |
2003-02-11 |
3M Innovative Properties Company |
Imidazonaphthyridines
|
US20020058674A1
(en)
|
1999-01-08 |
2002-05-16 |
Hedenstrom John C. |
Systems and methods for treating a mucosal surface
|
US6558951B1
(en)
*
|
1999-02-11 |
2003-05-06 |
3M Innovative Properties Company |
Maturation of dendritic cells with immune response modifying compounds
|
US6331539B1
(en)
|
1999-06-10 |
2001-12-18 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
US6756382B2
(en)
|
1999-06-10 |
2004-06-29 |
3M Innovative Properties Company |
Amide substituted imidazoquinolines
|
US6541485B1
(en)
|
1999-06-10 |
2003-04-01 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
US6573273B1
(en)
|
1999-06-10 |
2003-06-03 |
3M Innovative Properties Company |
Urea substituted imidazoquinolines
|
US6916925B1
(en)
|
1999-11-05 |
2005-07-12 |
3M Innovative Properties Co. |
Dye labeled imidazoquinoline compounds
|
US6376669B1
(en)
|
1999-11-05 |
2002-04-23 |
3M Innovative Properties Company |
Dye labeled imidazoquinoline compounds
|
JP3436512B2
(ja)
*
|
1999-12-28 |
2003-08-11 |
株式会社デンソー |
アクセル装置
|
US6894060B2
(en)
|
2000-03-30 |
2005-05-17 |
3M Innovative Properties Company |
Method for the treatment of dermal lesions caused by envenomation
|
US6525064B1
(en)
|
2000-12-08 |
2003-02-25 |
3M Innovative Properties Company |
Sulfonamido substituted imidazopyridines
|
US6660747B2
(en)
*
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
US6664260B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Heterocyclic ether substituted imidazoquinolines
|
US6664264B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US6667312B2
(en)
*
|
2000-12-08 |
2003-12-23 |
3M Innovative Properties Company |
Thioether substituted imidazoquinolines
|
US20020107262A1
(en)
*
|
2000-12-08 |
2002-08-08 |
3M Innovative Properties Company |
Substituted imidazopyridines
|
US6677347B2
(en)
*
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamido ether substituted imidazoquinolines
|
US6660735B2
(en)
*
|
2000-12-08 |
2003-12-09 |
3M Innovative Properties Company |
Urea substituted imidazoquinoline ethers
|
UA74852C2
(en)
|
2000-12-08 |
2006-02-15 |
3M Innovative Properties Co |
Urea-substituted imidazoquinoline ethers
|
US6545017B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Urea substituted imidazopyridines
|
US6545016B1
(en)
|
2000-12-08 |
2003-04-08 |
3M Innovative Properties Company |
Amide substituted imidazopyridines
|
US6664265B2
(en)
|
2000-12-08 |
2003-12-16 |
3M Innovative Properties Company |
Amido ether substituted imidazoquinolines
|
UA74593C2
(en)
*
|
2000-12-08 |
2006-01-16 |
3M Innovative Properties Co |
Substituted imidazopyridines
|
AU2006216669A1
(en)
*
|
2000-12-08 |
2006-08-31 |
3M Innovative Properties Company |
Compositions and methods for targeted delivery of immune response modifiers
|
WO2002046749A2
(fr)
*
|
2000-12-08 |
2002-06-13 |
3M Innovative Properties Company |
Procede de criblage permettant d'identifier des composes qui induisent de maniere selective la production d'interferon alpha
|
US6677348B2
(en)
*
|
2000-12-08 |
2004-01-13 |
3M Innovative Properties Company |
Aryl ether substituted imidazoquinolines
|
KR100766851B1
(ko)
*
|
2001-03-02 |
2007-10-16 |
씨제이 주식회사 |
신규한 α-케토 아미드 유도체 및 그의 제조 방법
|
US7226928B2
(en)
*
|
2001-06-15 |
2007-06-05 |
3M Innovative Properties Company |
Methods for the treatment of periodontal disease
|
MXPA04001972A
(es)
*
|
2001-08-30 |
2005-02-17 |
3M Innovative Properties Co |
Metodos para hacer madurar celulas dendricas plasmacitoide utilizando moleculas modificadoras de respuesta enmune.
|
DE60230340D1
(de)
*
|
2001-11-16 |
2009-01-22 |
3M Innovative Properties Co |
N-Ä4-(4-Amino-2-ethyl-1H-imidazoÄ4,5-cÜchinolin-1-yl)butylÜmethanesulfonamide, diese enthaltende pharmazeutische Zusammensetzung und deren Verwendung
|
US20030199538A1
(en)
*
|
2001-11-29 |
2003-10-23 |
3M Innovative Properties Company |
Pharmaceutical formulation comprising an immune response modifier
|
CA2365732A1
(fr)
*
|
2001-12-20 |
2003-06-20 |
Ibm Canada Limited-Ibm Canada Limitee |
Etalonnages
|
US6677349B1
(en)
*
|
2001-12-21 |
2004-01-13 |
3M Innovative Properties Company |
Sulfonamide and sulfamide substituted imidazoquinolines
|
PT1474425E
(pt)
*
|
2002-01-07 |
2006-09-29 |
Eisai Co Ltd |
Desazapurinas e sua utilizacao
|
CA2475595C
(fr)
*
|
2002-02-22 |
2012-07-10 |
3M Innovative Properties Company |
Procede visant a reduire et a traiter l'immunodepression induite par uv-b
|
GB0211649D0
(en)
*
|
2002-05-21 |
2002-07-03 |
Novartis Ag |
Organic compounds
|
MXPA04012199A
(es)
*
|
2002-06-07 |
2005-02-25 |
3M Innovative Properties Co |
Imidazopiridinas sustituidas con eter.
|
BR0313587A
(pt)
|
2002-08-15 |
2006-06-13 |
3M Innovative Properties Co |
composições imunoestimuladoras e métodos de estimulação de uma resposta imune
|
EP1542688A4
(fr)
*
|
2002-09-26 |
2010-06-02 |
3M Innovative Properties Co |
Dimeres 1h-imidazo
|
WO2004053057A2
(fr)
*
|
2002-12-11 |
2004-06-24 |
3M Innovative Properties Company |
Systemes d'expression genetique et lignees cellulaires de recombinaison
|
AU2003287316A1
(en)
*
|
2002-12-11 |
2004-06-30 |
3M Innovative Properties Company |
Assays relating to toll-like receptor activity
|
US7091214B2
(en)
|
2002-12-20 |
2006-08-15 |
3M Innovative Properties Co. |
Aryl substituted Imidazoquinolines
|
CA2511538C
(fr)
|
2002-12-30 |
2013-11-26 |
3M Innovative Properties Company |
Complexes immunostimulants
|
EP1592302A4
(fr)
*
|
2003-02-13 |
2007-04-25 |
3M Innovative Properties Co |
Procedes et compositions associes a des composes modificateurs de reponse immunitaire et recepteur 8 de type toll
|
US7485432B2
(en)
*
|
2003-02-27 |
2009-02-03 |
3M Innovative Properties Company |
Selective modulation of TLR-mediated biological activity
|
JP2006519866A
(ja)
|
2003-03-04 |
2006-08-31 |
スリーエム イノベイティブ プロパティズ カンパニー |
Uv誘発性の表皮の新形成の予防的治療
|
US7163947B2
(en)
*
|
2003-03-07 |
2007-01-16 |
3M Innovative Properties Company |
1-Amino 1H-imidazoquinolines
|
EP1605943A4
(fr)
*
|
2003-03-07 |
2008-01-16 |
3M Innovative Properties Co |
1-amino 1h-imidazoquinolines
|
AU2004220465A1
(en)
|
2003-03-13 |
2004-09-23 |
3M Innovative Properties Company |
Method of tattoo removal
|
EP1608282A4
(fr)
*
|
2003-03-13 |
2010-12-08 |
3M Innovative Properties Co |
Methodes de diagnostic de lesions de la peau
|
CA2518282C
(fr)
*
|
2003-03-13 |
2012-11-06 |
3M Innovative Properties Company |
Procedes pour ameliorer la qualite de la peau
|
US20040192585A1
(en)
*
|
2003-03-25 |
2004-09-30 |
3M Innovative Properties Company |
Treatment for basal cell carcinoma
|
EP1608369B1
(fr)
*
|
2003-03-28 |
2013-06-26 |
Novartis Vaccines and Diagnostics, Inc. |
Utilisation de composés organiques pour l'immunopotentialisation
|
AU2004229478B2
(en)
*
|
2003-04-10 |
2009-12-24 |
3M Innovative Properties Company |
Delivery of immune response modifier compounds
|
US20040265351A1
(en)
|
2003-04-10 |
2004-12-30 |
Miller Richard L. |
Methods and compositions for enhancing immune response
|
AR044466A1
(es)
*
|
2003-06-06 |
2005-09-14 |
3M Innovative Properties Co |
Proceso para la preparacion de imidazo [4,5-c] piridin-4-aminas
|
US6943255B2
(en)
*
|
2003-06-06 |
2005-09-13 |
3M Innovative Properties Company |
Process for imidazo[4,5-c]pyridin-4-amines
|
US20080063714A1
(en)
*
|
2003-07-31 |
2008-03-13 |
Hassan Sahouani |
Compositions for Encapsulation and Controlled Release
|
AU2004264330A1
(en)
*
|
2003-08-05 |
2005-02-24 |
3M Innovative Properties Company |
Infection prophylaxis using immune response modifier compounds
|
MXPA06001674A
(es)
*
|
2003-08-12 |
2006-05-12 |
3M Innovative Properties Co |
Compuestos que contienen imidazo hidroxilamina-sustituidos.
|
JP4913593B2
(ja)
*
|
2003-08-14 |
2012-04-11 |
スリーエム イノベイティブ プロパティズ カンパニー |
脂質修飾された免疫応答調整剤
|
WO2005018555A2
(fr)
*
|
2003-08-14 |
2005-03-03 |
3M Innovative Properties Company |
Modificateurs de la reponse immunitaire a modification lipidique
|
AU2004266162A1
(en)
*
|
2003-08-25 |
2005-03-03 |
3M Innovative Properties Company |
Immunostimulatory combinations and treatments
|
CA2536249A1
(fr)
|
2003-08-25 |
2005-03-10 |
3M Innovative Properties Company |
Administration de composes modificateurs de la reponse immunitaire
|
BRPI0413998A
(pt)
|
2003-08-27 |
2006-11-07 |
3M Innovative Properties Co |
imidazoquinolinas arilóxi e arilalquilenóxi substituìdas
|
CN1845736A
(zh)
*
|
2003-09-02 |
2006-10-11 |
3M创新有限公司 |
治疗粘膜相关病症的方法
|
AU2004270201A1
(en)
|
2003-09-05 |
2005-03-17 |
3M Innovative Properties Company |
Treatment for CD5+ B cell lymphoma
|
MXPA06003705A
(es)
|
2003-10-03 |
2006-06-20 |
3M Innovative Properties Co |
Imidazoquinolinas sustituidas con alcoxi.
|
MY146124A
(en)
|
2003-10-03 |
2012-06-29 |
3M Innovative Properties Co |
Pyrazolopyridines and analogs thereof
|
US7544697B2
(en)
|
2003-10-03 |
2009-06-09 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridines and analogs thereof
|
JP2007509987A
(ja)
*
|
2003-10-31 |
2007-04-19 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答調節剤化合物による好中球活性化
|
WO2005048933A2
(fr)
*
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Composes d'un anneau d'imidazo substitues par oxime
|
CA2545825A1
(fr)
|
2003-11-14 |
2005-06-02 |
3M Innovative Properties Company |
Composes d'un anneau d'imidazo substitue par hydroxylamine
|
WO2005051324A2
(fr)
*
|
2003-11-25 |
2005-06-09 |
3M Innovative Properties Company |
Hydroxylamine, et imidazoquinoleines, et imidazopyridines et imidazonaphtyridine substitues d'oxime
|
US8691837B2
(en)
|
2003-11-25 |
2014-04-08 |
3M Innovative Properties Company |
Substituted imidazo ring systems and methods
|
US20050226878A1
(en)
*
|
2003-12-02 |
2005-10-13 |
3M Innovative Properties Company |
Therapeutic combinations and methods including IRM compounds
|
EP1689361A4
(fr)
*
|
2003-12-02 |
2009-06-17 |
3M Innovative Properties Co |
Combinaisons therapeutiques et methodes faisant appel a des composes irm
|
TW200533352A
(en)
*
|
2003-12-04 |
2005-10-16 |
3M Innovative Properties Co |
Sulfone substituted imidazo ring ethers
|
US8802853B2
(en)
|
2003-12-29 |
2014-08-12 |
3M Innovative Properties Company |
Arylalkenyl and arylalkynyl substituted imidazoquinolines
|
US7888349B2
(en)
*
|
2003-12-29 |
2011-02-15 |
3M Innovative Properties Company |
Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds
|
AU2004312508A1
(en)
|
2003-12-30 |
2005-07-21 |
3M Innovative Properties Company |
Imidazoquinolinyl, imidazopyridinyl, and imidazonaphthyridinyl sulfonamides
|
JP2007517055A
(ja)
*
|
2003-12-30 |
2007-06-28 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫応答の増強
|
EP1729768B1
(fr)
|
2004-03-15 |
2018-01-10 |
Meda AB |
Formulations modificatrices de reponse immunitaire et procedes correspondants
|
AU2005228150A1
(en)
|
2004-03-24 |
2005-10-13 |
3M Innovative Properties Company |
Amide substituted imidazopyridines, imidazoquinolines, and imidazonaphthyridines
|
US7914769B2
(en)
*
|
2004-04-08 |
2011-03-29 |
University Of Massachusetts |
Compounds for treating human papillomavirus
|
JP2007532572A
(ja)
*
|
2004-04-09 |
2007-11-15 |
スリーエム イノベイティブ プロパティズ カンパニー |
免疫反応調整剤を送達させるための方法、組成物および調製物
|
CA2564855A1
(fr)
*
|
2004-04-28 |
2005-10-28 |
3M Innovative Properties Company |
Compositions et methodes pour vaccination muqueuse
|
US20050267145A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Merrill Bryon A |
Treatment for lung cancer
|
US20080015184A1
(en)
*
|
2004-06-14 |
2008-01-17 |
3M Innovative Properties Company |
Urea Substituted Imidazopyridines, Imidazoquinolines, and Imidazonaphthyridines
|
WO2005123080A2
(fr)
|
2004-06-15 |
2005-12-29 |
3M Innovative Properties Company |
Imidazoquinolines et imidazonaphthyridines substituees par un heterocyclyle contenant un azote
|
US8026366B2
(en)
|
2004-06-18 |
2011-09-27 |
3M Innovative Properties Company |
Aryloxy and arylalkyleneoxy substituted thiazoloquinolines and thiazolonaphthyridines
|
US7897609B2
(en)
|
2004-06-18 |
2011-03-01 |
3M Innovative Properties Company |
Aryl substituted imidazonaphthyridines
|
AU2005283085B2
(en)
*
|
2004-06-18 |
2012-06-21 |
3M Innovative Properties Company |
Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
|
WO2006065280A2
(fr)
|
2004-06-18 |
2006-06-22 |
3M Innovative Properties Company |
Composes a noyau imidazo a substitutif d'isoxazole, de dihydroisoxazole et d'oxadiazole
|
US8541438B2
(en)
|
2004-06-18 |
2013-09-24 |
3M Innovative Properties Company |
Substituted imidazoquinolines, imidazopyridines, and imidazonaphthyridines
|
US20060045886A1
(en)
*
|
2004-08-27 |
2006-03-02 |
Kedl Ross M |
HIV immunostimulatory compositions
|
CA2578975A1
(fr)
|
2004-09-02 |
2006-03-16 |
3M Innovative Properties Company |
Systemes cycliques de 2-amino 1h imidazo et procedes correspondants
|
PL1789042T3
(pl)
*
|
2004-09-02 |
2012-09-28 |
3M Innovative Properties Co |
Układy pierścieni 1-alkoksy 1H-imidazo i sposoby
|
US20080193468A1
(en)
*
|
2004-09-08 |
2008-08-14 |
Children's Medical Center Corporation |
Method for Stimulating the Immune Response of Newborns
|
US20070243215A1
(en)
*
|
2004-10-08 |
2007-10-18 |
Miller Richard L |
Adjuvant for Dna Vaccines
|
US8080560B2
(en)
*
|
2004-12-17 |
2011-12-20 |
3M Innovative Properties Company |
Immune response modifier formulations containing oleic acid and methods
|
AU2005322898B2
(en)
|
2004-12-30 |
2011-11-24 |
3M Innovative Properties Company |
Chiral fused (1,2)imidazo(4,5-c) ring compounds
|
SI1830876T1
(sl)
|
2004-12-30 |
2015-08-31 |
Meda Ab |
Uporaba imikvimoda za zdravljenje kožnih metastaz, ki izhajajo iz rakavega tumorja dojke
|
US20080188513A1
(en)
*
|
2004-12-30 |
2008-08-07 |
Taked Pharmaceutical Company Limited |
1-(2-Methylpropyl)-1H-Imidazo[4,5-C](1,5]Naphthyridin-4-Amine Ethanesulfonate and 1-(2-Methylpropyl)-1H-Imidazo[4,5-C](1,5]Naphthyridin-4-Amine Methanesulfonate
|
US8436176B2
(en)
*
|
2004-12-30 |
2013-05-07 |
Medicis Pharmaceutical Corporation |
Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine
|
EP1831221B1
(fr)
|
2004-12-30 |
2012-08-08 |
3M Innovative Properties Company |
Composes chiraux 1,2 imidazo 4,5-c substitues a noyau fusionne
|
CA2595994A1
(fr)
|
2005-01-27 |
2006-08-03 |
Alma Mater Studiorum - Universita' Di Bologna |
Composes organiques convenant pour le traitement de la maladie d'alzheimer, utilisation et methode de fabrication
|
EP1844201B1
(fr)
|
2005-02-04 |
2016-08-24 |
3M Innovative Properties Company |
Formulations des gel aqueux contenant des modificateurs de reponse immunitaire
|
EP1877056A2
(fr)
|
2005-02-09 |
2008-01-16 |
Coley Pharmaceutical Group, Inc. |
Composes cycliques thiazoloý4,5-c¨a substitution oxime et hydroxylamine et procedes associés
|
ES2475728T3
(es)
|
2005-02-09 |
2014-07-11 |
3M Innovative Properties Company |
Tiazoloquinolinas y tiazolonaftiridinas sustituidas con alcoxi
|
CA2597587A1
(fr)
|
2005-02-11 |
2006-08-17 |
Coley Pharmaceutical Group, Inc. |
Composes cycliques imidazo[4,5-c] substitues par oxime et hydroxylamine et procedes associes
|
JP2008532933A
(ja)
*
|
2005-02-11 |
2008-08-21 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
置換イミダゾキノリン類および置換イミダゾナフチリジン類
|
JP2008531567A
(ja)
|
2005-02-23 |
2008-08-14 |
コーリー ファーマシューティカル グループ,インコーポレイテッド |
ヒドロキシアルキル置換イミダゾキノリン化合物および方法
|
WO2006091647A2
(fr)
|
2005-02-23 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Methode d'induction preferentielle de la biosynthese d'interferon
|
AU2006223634A1
(en)
|
2005-02-23 |
2006-09-21 |
Coley Pharmaceutical Group, Inc. |
Hydroxyalkyl substituted imidazoquinolines
|
AU2006216799A1
(en)
|
2005-02-23 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Hydroxyalkyl substituted imidazonaphthyridines
|
MX2007011112A
(es)
|
2005-03-14 |
2007-11-07 |
Graceway Pharmaceuticals Llc |
Metodo para tratar queratosis actinica.
|
EP1869043A2
(fr)
|
2005-04-01 |
2007-12-26 |
Coley Pharmaceutical Group, Inc. |
Pyrazolopyridine-1,4-diamines et analogues associes
|
US7943636B2
(en)
|
2005-04-01 |
2011-05-17 |
3M Innovative Properties Company |
1-substituted pyrazolo (3,4-C) ring compounds as modulators of cytokine biosynthesis for the treatment of viral infections and neoplastic diseases
|
CA2605808A1
(fr)
*
|
2005-04-25 |
2006-11-02 |
3M Innovative Properties Company |
Compositions immunostimulantes
|
ZA200803029B
(en)
*
|
2005-09-09 |
2009-02-25 |
Coley Pharm Group Inc |
Amide and carbamate derivatives of alkyl substituted /V-[4-(4-amino-1H-imidazo[4,5-c] quinolin-1-yl)butyl] methane-sulfonamides and methods
|
US8476292B2
(en)
|
2005-09-09 |
2013-07-02 |
3M Innovative Properties Company |
Amide and carbamate derivatives of N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c] quinolin-1-Yl]-1,1-dimethylethyl}methanesulfonamide and methods
|
US8889154B2
(en)
|
2005-09-15 |
2014-11-18 |
Medicis Pharmaceutical Corporation |
Packaging for 1-(2-methylpropyl)-1H-imidazo[4,5-c] quinolin-4-amine-containing formulation
|
AU2006311871B2
(en)
*
|
2005-11-04 |
2011-03-03 |
3M Innovative Properties Company |
Hydroxy and alkoxy substituted 1H-imidazoquinolines and methods
|
US8951528B2
(en)
*
|
2006-02-22 |
2015-02-10 |
3M Innovative Properties Company |
Immune response modifier conjugates
|
US8329721B2
(en)
|
2006-03-15 |
2012-12-11 |
3M Innovative Properties Company |
Hydroxy and alkoxy substituted 1H-imidazonaphthyridines and methods
|
WO2008008432A2
(fr)
|
2006-07-12 |
2008-01-17 |
Coley Pharmaceutical Group, Inc. |
Composés à cycle [1,2] imidazo [4,5-c] fusionné chiral substitué et procédés correspondants
|
WO2008030511A2
(fr)
|
2006-09-06 |
2008-03-13 |
Coley Pharmaceuticial Group, Inc. |
3, 4, 6, 7-tétrahydro-5h-1, 2a, 4a, 8-tétraazacyclopenta[cd]phénalènes substitués
|
US20080149123A1
(en)
|
2006-12-22 |
2008-06-26 |
Mckay William D |
Particulate material dispensing hairbrush with combination bristles
|
US8436178B2
(en)
*
|
2007-05-08 |
2013-05-07 |
Astrazeneca Ab |
Imidazoquinolines with immuno-modulating properties
|
MX2010010511A
(es)
*
|
2008-03-24 |
2011-04-05 |
4Sc Ag |
Imidazoquinolinas substituidas novedosas.
|
KR101730351B1
(ko)
|
2009-03-25 |
2017-04-28 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
병원체에 대한 포유동물의 선천성 면역 저항성의 자극을 위한 조성물
|
US20110033515A1
(en)
*
|
2009-08-04 |
2011-02-10 |
Rst Implanted Cell Technology |
Tissue contacting material
|
US9242980B2
(en)
|
2010-08-17 |
2016-01-26 |
3M Innovative Properties Company |
Lipidated immune response modifier compound compositions, formulations, and methods
|
EP2480253B1
(fr)
*
|
2010-09-01 |
2014-01-22 |
Novartis AG |
Adsorption d'immunopotentiateurs sur des sels métalliques insolubles
|
ES2575688T3
(es)
|
2010-12-16 |
2016-06-30 |
Sumitomo Dainippon Pharma Co., Ltd. |
Derivado de imidazo[4,5-c]quinolin-1-ilo útil en terapia
|
US8728486B2
(en)
|
2011-05-18 |
2014-05-20 |
University Of Kansas |
Toll-like receptor-7 and -8 modulatory 1H imidazoquinoline derived compounds
|
WO2012167081A1
(fr)
|
2011-06-03 |
2012-12-06 |
3M Innovative Properties Company |
Hydrazino 1h-imidazoquinoléine-4-amines et conjugués obtenus à partir de celles-ci
|
EP2717919B1
(fr)
|
2011-06-03 |
2016-08-03 |
3M Innovative Properties Company |
Lieurs hétérobifonctionnels comportant de segments de polyéthylène glycol et conjugués modificateurs de réponse immunitaire obtenus à partir de ceux-ci
|
US20130023736A1
(en)
|
2011-07-21 |
2013-01-24 |
Stanley Dale Harpstead |
Systems for drug delivery and monitoring
|
EP3563865A3
(fr)
|
2012-05-04 |
2019-12-04 |
Pfizer Inc |
Régimes immunothérapeutiques basés sur des antigènes associés à la prostate et un vaccin
|
CN112587671A
(zh)
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
CN107312039B
(zh)
|
2012-08-30 |
2019-06-25 |
江苏豪森药业集团有限公司 |
一种替诺福韦前药的制备方法
|
CN105025854A
(zh)
|
2013-01-07 |
2015-11-04 |
宾夕法尼亚大学董事会 |
治疗皮肤t细胞淋巴瘤的组合物和方法
|
WO2015011254A1
(fr)
|
2013-07-26 |
2015-01-29 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Procédés et compositions pharmaceutiques pour le traitement d'infections bactériennes
|
WO2015069535A1
(fr)
|
2013-11-05 |
2015-05-14 |
3M Innovative Properties Company |
Formulations d'injection a base d'huile de sesame
|
KR102412220B1
(ko)
*
|
2013-12-24 |
2022-06-23 |
온코타르티스, 아이엔씨. |
벤즈아미드 및 니코틴아미드 화합물 및 이를 사용하는 방법
|
CN105899539B
(zh)
|
2014-01-10 |
2021-11-09 |
博笛生物科技有限公司 |
用于免疫疗法的化合物和组合物
|
WO2015125820A1
(fr)
|
2014-02-18 |
2015-08-27 |
サヴィッド・セラピューティックス株式会社 |
Variant de biotine, mutant de streptavidine, et leurs utilisations
|
HUE049656T2
(hu)
*
|
2014-04-22 |
2020-10-28 |
Hoffmann La Roche |
4-amino-imidazo-kinolin vegyületek
|
JP6760919B2
(ja)
|
2014-07-09 |
2020-09-23 |
バーディー バイオファーマシューティカルズ インコーポレイテッド |
腫瘍を治療するための抗pd−l1組み合わせ
|
CN105233291A
(zh)
|
2014-07-09 |
2016-01-13 |
博笛生物科技有限公司 |
用于治疗癌症的联合治疗组合物和联合治疗方法
|
CN112587672A
(zh)
|
2014-09-01 |
2021-04-02 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-pd-l1结合物
|
US10286065B2
(en)
|
2014-09-19 |
2019-05-14 |
Board Of Regents, The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
WO2016180852A1
(fr)
|
2015-05-12 |
2016-11-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Procédés de préparation de cellules t spécifiques de l'antigène à partir d'un échantillon de sang de cordon ombilical
|
EP3298131B1
(fr)
|
2015-05-20 |
2023-04-26 |
The Regents of The University of California |
Procédé pour générer des cellules dendritiques humaines pour l'immunothérapie
|
JP6956071B2
(ja)
*
|
2015-08-31 |
2021-10-27 |
スリーエム イノベイティブ プロパティズ カンパニー |
置換グアニジン基を含有するイミダゾ[4,5−c]環状化合物
|
KR102685007B1
(ko)
*
|
2015-08-31 |
2024-07-12 |
쓰리엠 이노베이티브 프로퍼티즈 컴파니 |
구아니딘 치환된 이미다조[4,5-c] 고리 화합물
|
JP6873980B2
(ja)
*
|
2015-09-14 |
2021-05-19 |
ファイザー・インク |
LRRK2阻害薬としての新規のイミダゾ[4,5−c]キノリンおよびイミダゾ[4,5−c][1,5]ナフチリジン誘導体
|
WO2017058996A1
(fr)
|
2015-09-29 |
2017-04-06 |
The University Of Chicago |
Vaccins à conjugués de polymère
|
WO2017059280A1
(fr)
|
2015-10-02 |
2017-04-06 |
The University Of North Carolina At Chapel Hill |
Nouveaux inhibiteurs de pan-tam et doubles inhibiteurs de mer/axl
|
MX2018005274A
(es)
|
2015-10-30 |
2019-09-19 |
The Regents Of The Universtiy Of California |
Metodos para la generacion de celulas-t a partir de celulas madre y metodos inmunoterapeuticos que utilizan las celulas-t.
|
CN115554406A
(zh)
|
2016-01-07 |
2023-01-03 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-cd20组合
|
CN106943597A
(zh)
|
2016-01-07 |
2017-07-14 |
博笛生物科技(北京)有限公司 |
用于治疗肿瘤的抗-egfr组合
|
CN106943598A
(zh)
|
2016-01-07 |
2017-07-14 |
博笛生物科技(北京)有限公司 |
用于治疗肿瘤的抗-her2组合
|
CN109843327B
(zh)
|
2016-07-07 |
2022-05-13 |
小利兰·斯坦福大学托管委员会 |
抗体佐剂缀合物
|
EP3504215B1
(fr)
|
2016-08-26 |
2022-04-06 |
3M Innovative Properties Company |
Composés cycliques [1,2]imidazo [4,5-c]fusionnés substitués par des groupes guanidino
|
US11826422B2
(en)
|
2016-11-09 |
2023-11-28 |
Board Of Regents, The University Of Texas System |
Methods and compositions for adaptive immune modulation
|
WO2018160552A1
(fr)
|
2017-03-01 |
2018-09-07 |
3M Innovative Properties Company |
Composés comprenant un cycle imidazo[4,5-c] contenant des groupes benzamide à substitution guanidine
|
KR101995533B1
(ko)
*
|
2017-03-21 |
2019-07-02 |
한국화학연구원 |
[1,2,4]트리아졸로[4,3-a]퀴노잘린 아미노 페닐 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 BET 단백질 관련 질환의 예방 또는 치료용 약학적 조성물
|
CN108794467A
(zh)
|
2017-04-27 |
2018-11-13 |
博笛生物科技有限公司 |
2-氨基-喹啉衍生物
|
US11517567B2
(en)
|
2017-06-23 |
2022-12-06 |
Birdie Biopharmaceuticals, Inc. |
Pharmaceutical compositions
|
WO2019048036A1
(fr)
*
|
2017-09-06 |
2019-03-14 |
Biontech Ag |
Imidazoquinolines substituées
|
PL3679025T3
(pl)
|
2017-09-06 |
2022-07-11 |
BioNTech SE |
Podstawione imidazochinoliny jako agoniści tlr7
|
WO2019123178A1
(fr)
|
2017-12-20 |
2019-06-27 |
3M Innovative Properties Company |
Composés imidazo [4,5-c]quinoléine à substitution amide ayant un groupe de liaison à chaîne ramifiée destinés à être utilisés en tant que modificateur de la réponse immunitaire
|
EP3759129A1
(fr)
|
2018-02-28 |
2021-01-06 |
Pfizer Inc |
Variants d'il-15 et leurs utilisations
|
US11370788B2
(en)
|
2018-02-28 |
2022-06-28 |
3M Innovative Properties Company |
Substituted imidazo[4,5-c]quinoline compounds with an N-1 branched group
|
PE20210127A1
(es)
|
2018-05-23 |
2021-01-19 |
Pfizer |
Anticuerpos especificos para cd3 y sus usos
|
PE20210488A1
(es)
|
2018-05-23 |
2021-03-15 |
Pfizer |
Anticuerpos especificos para gucy2c y sus usos
|
EP3802536B1
(fr)
|
2018-05-24 |
2022-07-13 |
3M Innovative Properties Company |
Composés imidazo [4,5-c]quinoléine substitués par cycloalkyle n-1 ramifié, compositions et procédés
|
EP3887369B1
(fr)
|
2018-11-26 |
2024-05-08 |
Solventum Intellectual Properties Company |
Composés imidazo[4,5-c]quinoleines substitueés en n-1 par alkylether, compositions et procédés.
|
WO2020128893A1
(fr)
|
2018-12-21 |
2020-06-25 |
Pfizer Inc. |
Traitements combinés de cancer comprenant un agoniste de tlr
|
US20220226488A1
(en)
*
|
2019-02-12 |
2022-07-21 |
Ambrx, Inc. |
Compositions containing, methods and uses of antibody-tlr agonist conjugates
|
SG11202108752YA
(en)
|
2019-03-07 |
2021-09-29 |
BioNTech SE |
Process for the preparation of a substituted imidazoquinoline
|
JP2022525594A
(ja)
|
2019-03-15 |
2022-05-18 |
ボルト バイオセラピューティクス、インコーポレーテッド |
Her2を標的とする免疫結合体
|
CN113924297A
(zh)
|
2019-06-06 |
2022-01-11 |
3M创新有限公司 |
N-1支链烷基取代的咪唑并[4,5-c]喹啉化合物、组合物和方法
|
US20220194935A1
(en)
|
2019-06-12 |
2022-06-23 |
3M Innovative Properties Company |
Phenethyl substituted imidazo[4,5-c]quinoline compounds with an n-1 branched group
|
WO2021116420A1
(fr)
|
2019-12-13 |
2021-06-17 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Utilisation d'agonistes tlr7 et/ou tlr8 pour le traitement de la leptospirose
|
IL293926A
(en)
|
2019-12-17 |
2022-08-01 |
Pfizer |
Antibodies unique to d47, pd-l1 and their uses
|
JP2023514727A
(ja)
|
2020-02-21 |
2023-04-07 |
シルバーバック セラピューティックス インコーポレイテッド |
ネクチン-4抗体コンジュゲートおよびその使用
|
WO2021202921A1
(fr)
*
|
2020-04-01 |
2021-10-07 |
Altimmune Uk Limited |
Composés du type imidazoquinoline et leurs utilisations
|
JP2023532304A
(ja)
|
2020-07-01 |
2023-07-27 |
エーアールエス ファーマシューティカルズ オペレーションズ,インク. |
抗asgr1抗体コンジュゲートおよびその使用
|
CN116323668A
(zh)
|
2020-07-17 |
2023-06-23 |
辉瑞公司 |
治疗性抗体及其用途
|